Complexo Hospitalario Universitario de Ferrol
Centro de atención
![Foto de Complexo Hospitalario Universitario de Ferrol](/img/noimage.png)
![Foto de Instituto de Investigación Sanitaria Biocruces Bizkaia](/img/noimage_org.png)
Instituto de Investigación Sanitaria Biocruces Bizkaia
Barakaldo, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (14)
2024
-
Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment
European Journal of Ophthalmology, Vol. 34, Núm. 4, pp. 1217-1227
2022
-
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry
Seminars in Arthritis and Rheumatism, Vol. 55
-
Transcriptomic analysis of patients with clinical suspicion of maturity-onset diabetes of the young (MODY) with a negative genetic diagnosis
Orphanet journal of rare diseases, Vol. 17, Núm. 1, pp. 105
2021
-
Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))
Autoimmunity Reviews
-
Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy—the PVS-PREDIAPS strategy—to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial
Implementation Science, Vol. 16, Núm. 1
-
Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study
Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346
-
Inpatient Hyperglycemia Management and COVID-19
Diabetes Therapy, Vol. 12, Núm. 1, pp. 121-132
2020
-
A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe
DIABETES THERAPY, Vol. 11, Núm. 2, pp. 423-436
-
Consequences of COVID-19 on people with diabetes
Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 6, pp. 355-356
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066
-
Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes
Diabetes Research and Clinical Practice, Vol. 166
-
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Autoimmunity Reviews, Vol. 19, Núm. 5
2018
-
Bone metastasis located on foot as a clinical presentation of an adrenocortical carcinoma
Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 7, pp. 418-419
2016
-
A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome
Endocrine Pathology, Vol. 27, Núm. 2, pp. 142-146